These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7484027)

  • 41. The effect of succinylcholine on atracurium-induced neuromuscular block.
    Roed J; Larsen PB; Olsen JS; Engbaek J
    Acta Anaesthesiol Scand; 1997 Nov; 41(10):1331-4. PubMed ID: 9422301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade.
    Donati F; Smith CE; Bevan DR
    Anesth Analg; 1989 Jan; 68(1):13-9. PubMed ID: 2910133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholinesterase inhibitors do not prolong neuromuscular block produced by mivacurium.
    Fleming NW; Lewis BK
    Br J Anaesth; 1994 Aug; 73(2):241-3. PubMed ID: 7917744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of neostigmine or edrophonium on force of contraction when administered at a train-of-four ratio of 0.9 in anesthetized dogs.
    Romano M; Martin-Flores M; Sakai DM; Tseng CT; Campoy L; Gleed RD
    Vet Anaesth Analg; 2017 Nov; 44(6):1313-1320. PubMed ID: 29066245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Edrophonium and human plasma cholinesterase combination for antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Samarkandi AH; Bakhamees HS; Turkistani A; Alharby SW
    Br J Anaesth; 1996 Sep; 77(3):424-6. PubMed ID: 8949825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Edrophonium and plasma cholinesterase activity.
    Mirakhur RK
    Can Anaesth Soc J; 1986 Sep; 33(5):588-90. PubMed ID: 3768766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Priming reversal of profound atracurium blockade by edrophonium and neostigmine.
    Liu CH; Lin IS; Liu CG; Peng TH; Yeh YJ; Chuu LJ; Lin SY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 May; 11(5):257-64. PubMed ID: 7602663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
    Abdulatif M; Mowafi H; al-Ghamdi A; el-Sanabary M
    Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.
    Bevan JC; Tousignant C; Stephenson C; Blackman L; Reimer E; Smith MF; Bevan DR
    Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sepsis attenuates the intensity of the neuromuscular blocking effect of d-tubocurarine and the antagonistic actions of neostigmine and edrophonium accompanying depression of muscle contractility of the diaphragm.
    Narimatsu E; Nakayama Y; Sumita S; Iwasaki H; Fujimura N; Satoh K; Namiki A
    Acta Anaesthesiol Scand; 1999 Feb; 43(2):196-201. PubMed ID: 10027028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Profound atracurium induced neuromuscular blockade. A comparison of evoked reversal with edrophonium or neostigmine.
    Casson WR; Jones RM
    Anaesthesia; 1986 Apr; 41(4):382-5. PubMed ID: 3754698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antagonism of pancuronium- and pipecuronium-induced neuromuscular block.
    Gyermek L; Cantley EM; Lee C
    Br J Anaesth; 1995 Apr; 74(4):410-4. PubMed ID: 7734260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Different properties of the bradycardia produced by neostigmine and edrophonium in the cat.
    Backman SB; Stein RD; Blank DW; Collier B; Polosa C
    Can J Anaesth; 1996 Jul; 43(7):731-40. PubMed ID: 8807181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Muscle relaxants in small animal anesthesia.
    Lumb WV
    J Am Vet Med Assoc; 1972 Dec; 161(11):1436-41. PubMed ID: 4264297
    [No Abstract]   [Full Text] [Related]  

  • 56. Antagonism of neuromuscular blockade but not muscle relaxation affects depth of anaesthesia.
    Vasella FC; Frascarolo P; Spahn DR; Magnusson L
    Br J Anaesth; 2005 Jun; 94(6):742-7. PubMed ID: 15778268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
    Naguib M; Selim M; Bakhamees HS; Samarkandi AH; Turkistani A
    Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block.
    Beaufort TM; Nigrovic V; Proost JH; Houwertjes MC; Wierda JM
    Anesthesiology; 1998 Sep; 89(3):707-14. PubMed ID: 9743409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
    Abdulatif M; Al-Ghamdi A; Al-Sanabary M; Abdel-Gaffar ME
    Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
    Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P
    Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.